Zaray Miranda-Chacón

Nanobodies: COVID-19 and Future Perspectives

Anne D. Berking, A. Rojas-Fernandez, Ronald Jara, 2022, Frontiers in Drug Discovery.

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

T. Woodruff, T. Munro, E. Wolvetang, 2022, Molecular Psychiatry.

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike-ACE2 receptor interaction

T. Woodruff, T. Munro, K. Stacey, 2022, bioRxiv.

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody

J. Blesa, D. Schwefel, Anne D. Berking, 2020, Scientific Reports.

The 2022 South America report of The Lancet Countdown on health and climate change: trust the science. Now that we know, we must act.

M. Callaghan, D. Rojas-Rueda, N. Gouveia, 2023, Lancet regional health. Americas.

A critical analysis of national plans for climate adaptation for health in South America

R. Castillo-Neyra, Zaray Miranda-Chacón, Yasna K. Palmeiro-Silva, 2023, Lancet regional health. Americas.

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants

T. Mielke, C. Spahn, T. Munro, 2023, iScience.